CCC Chicago

In a historic policy shift, the Justice Department has proposed reclassifying marijuana from a Schedule I to a Schedule III substance. This decision, if finalized, would acknowledge the medical benefits of cannabis and categorize it with drugs like ketamine and some anabolic steroids. However, it...

“We are thrilled that the Senate Banking Committee has approved the SAFE Banking Bill,” said Boris Jordan, founder and chairman of Curaleaf Holdings, Inc. (OTCQX: CURLF), reflecting the sentiments of cannabis industry stakeholders following the historic approval of the...

Urban-Gro, Inc. (NASDAQ: UGRO), a comprehensive professional services consulting firm announced its latest contract win within the hospitality and recreation sector in the Southeastern U.S. The contract, valued at over $11 million, encompasses a range of services, including architecture,...

The world of cannabis and psychedelics is evolving at a rapid pace, with companies introducing groundbreaking products and expanding into new markets. From advanced cannabis delivery systems to organic mushroom grow kits, these innovations are not only reshaping consumer choices but also promoting...

In a pivotal moment for the American cannabis sector, the U.S. Department of Health and Human Services (HHS) has proposed a reclassification of cannabis to the DEA. This could shift cannabis from its current Schedule I status, bringing potential upheaval in the perception and market dynamics of the...

Cage-Free Repair, the non-profit arm of Cage-Free Cannabis, released its 2023 Cannabis Social Responsibility Report. Highlighting current social initiatives in the cannabis industry, the report covers comprehensive research on 20 leading North American cannabis firms, including names like...

"Let me know if you feel otherwise but I feel first and foremost whenever we’re talking to the CFOs of our businesses making sure you have a very good handle on what you need to survive...is of utmost importance," Brian Bacal, managing director, head of debt advisory,...

FundCanna, a premier capital provider to the cannabis sector, has partnered with Nabis, California's top wholesale and logistics provider for cannabis brands. According to a press release, this collaboration designates FundCanna as Nabis’ recommended lending associate, ensuring swift...

In the rapidly evolving world of cannabis journalism, it's the passionate, resilient and purpose-driven narratives that stand tall, illuminating the path for a more inclusive and diversified media landscape. As part of this ever-growing mission, the Benzinga Cannabis Capital Conference is...

The global cannabis landscape is undergoing rapid transformation as countries worldwide reevaluate their stance on this once-stigmatized plant. In this journey, we'll explore the latest updates from Brazil and Thailand, as well as delve into HRI's Report on Foreign Aid. But there's more...

The human body's ability to adapt and respond to stress is a subject of ongoing fascination and study. Recent research by Northwestern Medicine, published in the journal Cell Reports, has revealed a captivating facet of the endocannabinoid system (ECS), a crucial regulatory network in the...

The cannabis industry is constantly evolving and this week has seen an exciting array of new products hitting the market. From innovative vape cartridges to mushroom and cannabis-infused gummies and cutting-edge AI technology, cannabis companies are pushing the boundaries of creativity and...

On August 29, 2023, the U.S. Department of Health and Human Services (HHS) recommended the DEA reclassify marijuana and move it from Schedule I to Schedule III, following a review by the Food and Drug Administration (FDA), as part of a process initiated by President Joe Biden in...

“If you hate what’s going on in California, what are you going to do about it?” Roger Volodarsky, founder and CEO of Puffco, posed this question during his recent appearance on Benzinga's "Cannabis Insider" show. Volodarsky's sentiment extends beyond just...

Canada’s medical cannabis landscape is facing a profound transformation. Since the legalization of recreational marijuana in 2018, there has been a steep decline in both patient registrations and spending. The challenge now lies in deciphering the reasons and navigating future implications....